ELAN Elanco Animal Health Incorporated
Stock · NYSE · United States · Healthcare · US28414H1032
NowoTrade is an independent information site. It is not affiliated with, endorsed by or sponsored by Elanco Animal Health Incorporated, and has no access to any account you may have with it. The name and the logo belong to their owners.
Price
25.74 USD
+8.70%
52-week range
19.40 – 27.98
Dividend yield—
Market cap12.9B
NowoTrade score
25 Grade A
Price history
Daily prices in USD.
Updated 08 Nov 2026 14:27. Information, not advice.
Results
Next results
23 Feb 2027
in 107 days · 08:00 · estimate 0.18
Last results
0.27 vs 0.20 estimated
06 Nov 2026 · Beat +32.8%
Beat the estimate
10 of 12
2 missed · 0 in line · 7 beats in a row
Average surprise
+18.2%
reported against the estimate, last 12 quarters
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 23 Feb 2027 08:00 | 0.18 | — | — | Upcoming |
| 06 Nov 2026 06:00 | 0.20 | 0.27 | +32.8% | Beat |
| 05 Aug 2026 06:00 | 0.27 | 0.34 | +26.5% | Beat |
| 06 May 2026 06:00 | 0.34 | 0.40 | +16.6% | Beat |
| 24 Feb 2026 06:00 | 0.12 | 0.13 | +11.2% | Beat |
| 05 Nov 2025 06:00 | 0.13 | 0.19 | +43.9% | Beat |
| 07 Aug 2025 06:00 | 0.20 | 0.26 | +29.5% | Beat |
| 07 May 2025 06:00 | 0.30 | 0.37 | +21.5% | Beat |
| 25 Feb 2025 07:00 | 0.15 | 0.14 | -5.8% | Miss |
| 07 Nov 2024 06:00 | 0.12 | 0.13 | +11.0% | Beat |
| 08 Aug 2024 06:00 | 0.24 | 0.30 | +26.2% | Beat |
| 08 May 2024 06:00 | 0.27 | 0.34 | +28.0% | Beat |
| 26 Feb 2024 06:00 | 0.10 | 0.08 | -23.4% | Miss |
| 07 Nov 2023 06:00 | 0.12 | 0.18 | +52.0% | Beat |
| 07 Aug 2023 06:00 | 0.05 | 0.18 | +273.0% | Beat |
| 09 May 2023 06:00 | 0.29 | 0.45 | +57.3% | Beat |
| 21 Feb 2023 06:00 | 0.13 | 0.19 | +49.1% | Beat |
| 08 Nov 2022 06:00 | 0.16 | 0.20 | +27.1% | Beat |
| 08 Aug 2022 06:00 | 0.25 | 0.36 | +42.8% | Beat |
| 09 May 2022 06:00 | 0.35 | 0.36 | +2.4% | Beat |
| 24 Feb 2022 06:00 | 0.17 | 0.21 | +24.2% | Beat |
| 05 Nov 2021 06:00 | 0.17 | 0.19 | +14.9% | Beat |
| 09 Aug 2021 06:00 | 0.26 | 0.28 | +5.7% | Beat |
| 07 May 2021 06:00 | 0.23 | 0.37 | +63.2% | Beat |
| 24 Feb 2021 06:00 | 0.10 | 0.12 | +24.2% | Beat |
| 06 Nov 2020 06:00 | 0.12 | 0.13 | +6.0% | Beat |
| 30 Jul 2020 06:00 | 0.07 | 0.09 | +29.3% | Beat |
| 07 May 2020 07:00 | 0.24 | 0.13 | -45.5% | Miss |
| 19 Feb 2020 06:00 | 0.23 | 0.23 | -0.4% | In line |
| 06 Nov 2019 06:00 | 0.26 | 0.30 | +16.6% | Beat |
| 13 Aug 2019 06:00 | 0.26 | 0.28 | +9.8% | Beat |
| 09 May 2019 06:00 | 0.23 | 0.25 | +10.7% | Beat |
| 06 Feb 2019 06:00 | 0.27 | 0.29 | +5.5% | Beat |
| 06 Nov 2018 06:00 | 0.25 | 0.29 | +16.4% | Beat |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 4.7B | +6.2% | -232M | -4.9% | -0.47 | -169.1% | 284M |
| 2024 | 4.4B | +0.5% | 338M | 7.6% | 0.68 | +127.2% | 394M |
| 2023 | 4.4B | +0.1% | -1.2B | -27.9% | -2.50 | -1,566.7% | 131M |
| 2022 | 4.4B | — | -78M | -1.8% | -0.15 | — | 268M |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| Oct 2024 | 14.61 | 14.98 | 12.19 | 12.64 | -13.96% | 91,096,100 | |
| Sep 2024 | 15.31 | 15.78 | 13.28 | 14.69 | -5.04% | 103,549,100 | |
| Aug 2024 | 13.11 | 15.70 | 11.40 | 15.47 | +18.63% | 109,889,100 | |
| Jul 2024 | 14.46 | 14.76 | 12.57 | 13.04 | -9.63% | 114,899,500 | |
| Jun 2024 | 17.86 | 18.80 | 13.62 | 14.43 | -18.38% | 108,306,700 | |
| May 2024 | 13.10 | 17.84 | 12.99 | 17.68 | +34.35% | 113,393,200 | |
| Apr 2024 | 16.31 | 16.41 | 12.69 | 13.16 | -19.16% | 94,609,000 | |
| Mar 2024 | 15.92 | 16.73 | 15.52 | 16.28 | +2.45% | 64,829,400 | |
| Feb 2024 | 14.89 | 16.88 | 14.35 | 15.89 | +7.80% | 97,681,900 | |
| Jan 2024 | 14.67 | 15.94 | 13.91 | 14.74 | -1.07% | 106,535,300 | |
| Dec 2023 | 11.78 | 15.10 | 11.62 | 14.90 | +26.49% | 113,564,500 | |
| Nov 2023 | 8.79 | 12.31 | 8.59 | 11.78 | +33.71% | 114,090,000 | |
| Oct 2023 | 11.22 | 11.22 | 8.52 | 8.81 | -21.62% | 128,407,900 | |
| Sep 2023 | 12.34 | 12.62 | 11.02 | 11.24 | -7.87% | 89,125,200 | |
| Aug 2023 | 11.97 | 12.72 | 11.25 | 12.20 | +1.08% | 124,235,900 | |
| Jul 2023 | 10.03 | 12.53 | 9.57 | 12.07 | +19.98% | 131,280,600 | |
| Jun 2023 | 8.23 | 10.42 | 8.10 | 10.06 | +23.44% | 128,347,000 | |
| May 2023 | 9.42 | 9.65 | 7.88 | 8.15 | -13.94% | 193,421,500 | |
| Apr 2023 | 9.49 | 10.18 | 8.67 | 9.47 | +0.74% | 132,424,400 | |
| Mar 2023 | 11.45 | 11.64 | 8.68 | 9.40 | -18.05% | 209,267,000 | |
| Feb 2023 | 13.65 | 14.69 | 11.45 | 11.47 | -16.46% | 126,321,700 | |
| Jan 2023 | 12.41 | 14.25 | 12.02 | 13.73 | +12.36% | 144,394,100 | |
| Dec 2022 | 12.97 | 13.34 | 11.18 | 12.22 | -5.05% | 130,480,700 | |
| Nov 2022 | 13.41 | 13.84 | 11.72 | 12.87 | -2.43% | 167,198,600 | |
| Oct 2022 | 12.50 | 13.68 | 11.34 | 13.19 | +6.29% | 142,591,000 |
Page 2 of 3
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- Elanco Animal Health (ELAN) Stock Still Looks Cheap Following Its 141% Run (opens in a new tab) Simply Wall St. · 08 Nov 2026 04:19
- Earnings Beat Might Change The Case For Elanco Stock (ELAN) (opens in a new tab) Simply Wall St. · 07 Nov 2026 20:16
- What Just Happened With Elanco Animal Health (ELAN)? (opens in a new tab) Simply Wall St. · 07 Nov 2026 19:14
- Elanco Animal Health Q3 Earnings Call Highlights (opens in a new tab) MarketBeat · 07 Nov 2026 07:16
- Elanco Animal Health Incorporated 2026 Q3 - Results - Earnings Call Presentation (opens in a new tab) SeekingAlpha · 07 Nov 2026 04:01
- Elanco Animal Health Inc (ELAN) (Q3 2026) Earnings Call Highlights: Revenue Up 11%, Guidance ... (opens in a new tab) GuruFocus.com · 07 Nov 2026 03:14
- Elanco (ELAN) Q3 2026 Earnings Call Transcript (opens in a new tab) Motley Fool · 06 Nov 2026 18:49
- Elanco Animal Health Incorporated (ELAN) Q3 2026 Earnings Call Transcript (opens in a new tab) SeekingAlpha · 06 Nov 2026 16:04
- Elanco Animal Health Incorporated Reports Third Quarter 2026 Revenue of $1.265 billion (opens in a new tab) Fintel · 06 Nov 2026 15:01
- Elanco Animal Health Sees Strong Momentum Heading Into 2027 (opens in a new tab) Benzinga · 06 Nov 2026 14:39
- Elanco Animal Health (ELAN) Reports Q3 Earnings: What Key Metrics Have to Say (opens in a new tab) Zacks · 06 Nov 2026 13:30
- Elanco Animal Health Shares Jump 7.6% as Q3 Earnings Beat Forecasts and Company Raises 2026 Outlook (opens in a new tab) InvestorsHub · 06 Nov 2026 12:57
- Elanco Animal Health (NYSE:ELAN) Jumps on Q3 Earnings Beat and Raised Outlook (opens in a new tab) ChartMill · 06 Nov 2026 12:25
- Elanco’s (NYSE:ELAN) Q3 2026 sales beat estimates, stock soars (opens in a new tab) StockStory · 06 Nov 2026 12:24
- Elanco Animal Health Incorporated (ELAN) Q3 Earnings and Revenues Surpass Estimates (opens in a new tab) Zacks · 06 Nov 2026 11:35
Headlines link to the original articles of the publishers shown; NowoTrade does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 23.68 USD
- Market cap
- 12.9B
- Exchange
- NYSE
- Country
- United States
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Currency
- USD
Dividends
No dividends on record.
Why this score
| Part of the score | Points | Why |
|---|---|---|
| Business growth Yearly growth of revenue and of earnings per share. | 3.7 / 25 |
|
| Quality Return on equity, net margin and how stable the margins are. | 0.0 / 25 |
|
| Financial strength Net debt against operating earnings, interest cover and free cash flow. | 9.9 / 20 |
|
| Valuation Free cash flow yield and the P/E against its sector. | 12.0 / 15 |
|
| Analysts How far the analysts' average target is from today's price. | 9.7 / 10 |
|
- Thin interest cover: operating profit is only 1.1× the interest
- The last full year was a loss
Growth profile: it pays no dividend, so it is scored on business growth, quality and financial strength. Based on 95% of the figures (grade A). Warnings take 12 points off.
Warnings take points off and some cap the score. In your account the score also considers how the share fits your portfolio.
Figures
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| P/E (forward) | 20.16× | Fair | 14.89× |
| Price / book | 1.94× | Fair | 3.8× |
| Price / sales | 2.5× | Fair | 3.19× |
| EV / EBITDA | 15.39× | Weak | 12.61× |
| Free cash flow yield | 5.3% | Good | 2.5% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Gross margin | 56.2% | Good | 58.6% |
| Operating margin | 6.6% | Weak | 7.6% |
| Net margin | -2.9% | Weak | 2.7% |
| Return on equity | -2.2% | Weak | 5.7% |
| Return on assets | 1.8% | Weak | 3.5% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Revenue growth / year | 2.2% | Weak | 10.8% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Debt / equity | 0.61× | Good | 0.48× |
| Net debt / EBITDA | 3.33× | Weak | 1.6× |
| Interest cover | 1.15× | Weak | 2.65× |
| Current ratio | 2.09× | Good | 2.36× |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Payout of earnings | 0% | Weak | 0% |
The reading follows general rules of thumb and each sector has its own norms: compare with the sector median when it is shown. Information, not advice.
Follow ELAN and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.